1. Home
  2. WOK vs TLSA Comparison

WOK vs TLSA Comparison

Compare WOK & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOK
  • TLSA
  • Stock Information
  • Founded
  • WOK 2002
  • TLSA 2013
  • Country
  • WOK China
  • TLSA United Kingdom
  • Employees
  • WOK N/A
  • TLSA N/A
  • Industry
  • WOK
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • WOK
  • TLSA Health Care
  • Exchange
  • WOK NYSE
  • TLSA Nasdaq
  • Market Cap
  • WOK 79.5M
  • TLSA 87.8M
  • IPO Year
  • WOK 2024
  • TLSA 2000
  • Fundamental
  • Price
  • WOK $5.01
  • TLSA $1.00
  • Analyst Decision
  • WOK
  • TLSA
  • Analyst Count
  • WOK 0
  • TLSA 0
  • Target Price
  • WOK N/A
  • TLSA N/A
  • AVG Volume (30 Days)
  • WOK 161.9K
  • TLSA 262.0K
  • Earning Date
  • WOK 02-03-2025
  • TLSA 12-27-2024
  • Dividend Yield
  • WOK N/A
  • TLSA N/A
  • EPS Growth
  • WOK N/A
  • TLSA N/A
  • EPS
  • WOK N/A
  • TLSA N/A
  • Revenue
  • WOK $9,863,642.00
  • TLSA N/A
  • Revenue This Year
  • WOK N/A
  • TLSA N/A
  • Revenue Next Year
  • WOK N/A
  • TLSA N/A
  • P/E Ratio
  • WOK N/A
  • TLSA N/A
  • Revenue Growth
  • WOK N/A
  • TLSA N/A
  • 52 Week Low
  • WOK $3.26
  • TLSA $0.41
  • 52 Week High
  • WOK $8.45
  • TLSA $1.74
  • Technical
  • Relative Strength Index (RSI)
  • WOK N/A
  • TLSA 58.05
  • Support Level
  • WOK N/A
  • TLSA $0.88
  • Resistance Level
  • WOK N/A
  • TLSA $1.06
  • Average True Range (ATR)
  • WOK 0.00
  • TLSA 0.07
  • MACD
  • WOK 0.00
  • TLSA 0.00
  • Stochastic Oscillator
  • WOK 0.00
  • TLSA 74.95

About WOK WORK MEDICAL TECHNOLOGY GROUP LTD

WORK Medical Technology Group Ltd is a manufacturer of medical devices, and it is committed to providing professional and reliable medical devices to the world.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: